UK consults on plans for a single medical research regulator
This article was originally published in RAJ Devices
The UK's Academy of Medical Sciences is seeking feedback on the merits of placing responsibility for different aspects of medical research regulation, including that of clinical trials, within a "single research regulator"1.
You may also be interested in...
Citing challenges posed by the COVID-19 pandemic, EU regulators have extended the deadline for companies to finish nitrosamine-related risk evaluations.
The Australian health care products regulator is inviting feedback on proposed measures to clarify the boundary for software-based products that are captured under the regulatory framework for medical devices.
A draft EU guideline explains how companies can ensure that data from ongoing clinical trials remains relevant for regulatory decision-making despite problems posed by the COVID-19 pandemic.